Options for managing astigmatism in cataract surgery
Two physicians shared their thoughts on the various ways to manage astigmatism, what levels to treat, and how they decide the best option for each patient.
Browse articles from EyeWorld.org related to refractive surgery. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Two physicians shared their thoughts on the various ways to manage astigmatism, what levels to treat, and how they decide the best option for each patient.
Detecting irregular astigmatism early has taken on greater importance, particularly in the context of cataract surgery planning and patient satisfaction. Understanding how these findings are detected and why they matter clinically is becoming an essential part of preoperative evaluation, according to sources who weighed in on the topic.
Refractive Editor Karolinne Rocha, MD, PhD, shared her thoughts on the topics covered in the Refractive section of this issue. “… I regularly see patients who are unhappy after surgery, particularly among patients who are revealed to have irregular astigmatism on the topography missed preoperatively,” she said.
EyeWorld spoke with two experts on the topic of when the Ks don’t align—when misalignment is clinically significant, what can be done about it, and how it impacts lens choices.
In refractive surgery, achieving 20/20 vision has long been treated as the finish line. But experienced surgeons know that a perfect Snellen score doesn’t always translate into a satisfied patient. One surgeon thinks the true measure of success is something less quantifiable, but far more meaningful: a 20/happy outcome.
➤ First patients dosed in Phase 3 program evaluating sustained drug delivery for DME ➤ FDA accepts supplemental NDA for presbyopia treatment ➤ FDA grants IND to ocular inflammation, pain treatment for potential expanded indication ➤ Enrollment complete in Phase 3 trial evaluating retinitis pigmentosa therapy ➤ ASCRS news and events
➤ First patient treated with novel crosslinking approach for refractive error ➤ Multisociety working group established to set guidelines for modern IOL classification ➤ FDA reduces clinical trial requirement for new drugs to one pivotal trial ➤ ASCRS news and events
➤ Study: ‘revolutionary,’ ‘world-first’ treatment for vision-threatening condition restores sight ➤ IDE granted to tissue-based presbyopia solution ➤ Fast Track designation granted for geographic atrophy treatment ➤ Phase 1 results for Stargardt gene therapy ➤ Topline Phase 1b results from study comparing a next-gen treatment to faricimab ➤ Enrolled patients complete dosing in part of trial evaluating X-linked retinoschisis therapy ➤ Company news ➤ ASCRS news and events
The ocular surface impacts many ophthalmic subspecialties beyond cornea. Whether it’s within refractive surgery, cataract surgery, glaucoma therapy, or retina procedures, the ocular surface can affect outcomes for patients being treated by these subspecialists. Several anterior segment ophthalmologists spoke about the ocular surface and how it relates to their subspecialty.
➤ Insulin-based treatment for neurotropic keratitis advances ➤ Study evaluating implantable telescope in patients with late-stage AMD begins ➤ Registrational trial to begin for investigational neuroprotective therapy ➤ Enrollment complete in pivotal trials for wet AMD treatment ➤ ASCRS news and events